Clinical Trial Update: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage (PROHIBIT-ICH) [NA]

View source ↗

Summary

PROHIBIT-ICH, a clinical trial evaluating prevention of hypertensive brain injury after intracerebral hemorrhage by intensive BP control, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Snippet

Sponsor: University College, London | Conditions: Intracerebral Hemorrhage | NA | Status: TERMINATED